Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Xintian Pharmaceutical: Plans to sell no more than 1% of repurchased shares
Xintian Pharmaceutical announces that the company held a board meeting on April 2, 2026, to review and approve the proposal to sell some of the repurchased shares through centralized bidding trading. According to the previously disclosed “Report on Continuing Share Repurchase and the Announcement of the First Repurchase,” the board agreed that the company, within three months after the announcement is disclosed, i.e., from April 28, 2026, to July 27, 2026, will sell no more than 2.44M repurchased shares, accounting for 1% of the company’s total shares. The number of repurchased shares to be sold this time does not exceed the amount of shares specified in the company’s “Share Repurchase Report” to be sold through centralized bidding trading.